Latest Breaking News On - Rani therapeutics holdings inc - Page 1 : comparemela.com

Rani Therapeutics Holdings, Inc (NASDAQ:RANI) Short Interest Down 29 7% in May

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI – Get Free Report) saw a significant drop in short interest in the month of May. As of May 15th, there was short interest totalling 871,200 shares, a drop of 29.7% from the April 30th total of 1,240,000 shares. Based on an average daily volume of 148,400 shares, the days-to-cover […]

United statesExchange commissionRani therapeutics holdings incCanaccord genuity groupVanguard group incRani therapeutics holdingsGet free reportRani therapeuticsFree reportGenuity groupTherapeutics holdingsRani therapeutics daily

Zacks Small Cap Weighs in on Rani Therapeutics Holdings, Inc s FY2026 Earnings (NASDAQ:RANI)

Zacks Small Cap Weighs in on Rani Therapeutics Holdings, Inc s FY2026 Earnings (NASDAQ:RANI)
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United statesRani therapeutics holdings incVanguard group incCanaccord genuity groupExchange commissionRani therapeutics holdingsFree reportZacks small capRani therapeuticsSmall capRani therapeuticGet free reportGenuity groupTherapeutics stock downTherapeutics holdingsRani therapeutics daily

Rani Therapeutics Holdings, Inc (NASDAQ:RANI) Receives Consensus Rating of Buy from Analysts

Rani Therapeutics Holdings, Inc (NASDAQ:RANI) Receives Consensus Rating of Buy from Analysts
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United statesRani therapeutics holdings incCanaccord genuity groupRani therapeutics holdingsGet free reportMarketbeat ratingsRani therapeuticsGenuity groupTherapeutics stock downGet freeTherapeutics holdingsRani therapeutics daily

HC Wainwright Raises Rani Therapeutics (NASDAQ:RANI) Price Target to $13 00

HC Wainwright Raises Rani Therapeutics (NASDAQ:RANI) Price Target to $13 00
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United statesRani therapeutics holdings incCanaccord genuity groupRani therapeutics company profileRani therapeuticsGet free reportGenuity groupTherapeutics holdingsRani therapeutics daily

Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate Update

06.05.2024 - - Announced Positive Topline Results from Phase 1 Study of an Oral Anti-Interleukin 12/23 Antibody (RT-111) - - Initiation of Phase 2 clinical trial for RT-102 for the treatment of osteoporosis expected in 2024 - - RaniPill HC to be ready for .

Talat imranRani therapeutics holdings incExchange commissionCelltrion incDevelopment of ranipillTherapeutics holdingsChief executive officerSubsequent highlightsPositive topline resultsOral anti interleukinTerm milestone expectationsPrivate securities litigation reform actRani therapeutics holdingsMonths ended marchRani therapeutics holdings registereda chartAni therapeutics holdings registereda kurs